Nanotechnology products in Australia: Chemicals, cosmetics and regulatory character

New Global Frontiers in Regulation: The Age of Nanotechnology

Volumn , Issue , 2007, Pages 239-264

  Bowman, Diana ^a   Hodge, Graeme ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 56849091280     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (95)

1. Advanced Nanotechnology Limited (Advanced Nano) (2005), 'ZinClear - the choice is clear for cosmetic clarity and broad spectrum UV blocking', Perth: Advanced Nano.
2. Australian Academy of Science (2004), Nanotechnology Benchmarking Report, Canberra: Australian Academy of Science.
3. Australian Bureau of Statistics (2007), Population Clock as at 16 July 2007, Canberra.
4. Australian Council of Trade Unions (2005), Submission to the Senate Community Affairs Committee: Inquiry into Workplace Exposure to Toxic Dust, Melbourne: ACTU, accessed at www.aph.gov.au/senate/committee/clac_ctte/toxic_dust/submissions/sublist.html.
5. Australian Government (2005), Legislation Review: Prohibition of Human Cloning Act 2002 and the Research Involving Human Embryos Act 2002, Canberra: Australian Government.
6. Australian Institute for Bioengineering and Nanotechnology (2005), 'About the AIBN', accessed at www.aibn.uq.edu.au, 24 April 2006.
7. Australian Institute of Occupational Hygienists Inc (AIOH) (2005), 'AIOH submission - Senate Community Affairs Reference Committee, workplace exposure to toxic dust', Tullamarine: AIOH, accessed at www.aph.gov.au/senate/committee/clac_ctte/toxic_dust/submissions/sublist.html.
8. Australian Manufacturing Workers Union (AMWU) (2005), 'Submission from Australian Manufacturing Workers Union to the Senate Community Affairs Committee: inquiry into workplace exposure to toxic dust', Melbourne: AMWU, accessed at www.aph.gov.au/senate/committee/clac_ctte/toxic_dust/submissions/sublist.html.
9. Australian Pesticides and Veterinary Medicines Authority (APVMA) (2005a), APVMA Annual Report 2004-2005, Canberra: APVMA.
10. Australian Pesticides and Veterinary Medicines Authority (APVMA) (2005b), About the APVMA, Canberra: APVMA.
11. Australian Research Council (ARC) (2002), 'Designated priority areas of research 2002', accessed at www.arc.gov.au/grant_programs/priority_areas.htm, 24 April 2006.
12. Australian Research Council Nanotechnology Network (ARCNN) (2006), Annual Report, Canberra: ARCNN.
13. Balbus, J. M., K. Florini, R. Denison and S. Walsh (2005), 'Getting nanotechnology right the first time', Issues in Science and Technology, Summer, 65-71.
14. Binks, P. (2006), Personal Communication with Diana Bowman, Australian Nanotechnology Companies, 8 November, Melbourne.
15. Black, J. (1998), 'Regulation as facilitation: negotiating the genetic revolution', Modern Law Review, 61, 621-60.
16. Bowman, D. and G. Hodge (2006), 'Nanotechnology: mapping the wild regulatory frontier', Futures, 38, 1060-73.
17. Brumfiel, G. (2006), 'Consumer products leap aboard the bandwagon', Nature, 440 (16), 262.
18. Caulfield, T. (2003), 'The regulation of embryonic stem cell research: a few observations on the international scene', Health Law Journal, 87-95.
19. Centre for Quantum Computer Technology (2001), 'About', accessed at www.qcaustralia.org/home/htm, 20 June 2006.
20. Cohen, C. B. (1997), 'Unmanaged care: the need to regulate new reproductive technologies in the United States', Bioethics, 11 (3, 4), 348-65.
21. Cohen, J., A. Trounson, K. Dawson, H. Jones, J. Hazekamp, K. G. Nygren and L. Hamberger (2005), 'The early days of IVF outside the UK', Human Reproduction Update, 11 (5), 439-59.
22. Committee to Consider the Social Ethical and Legal Issues Arising from In Vitro Fertilization (1982), Interim Report, Melbourne: Victorian Government Printing Office.
23. Committee to Consider the Social Ethical and Legal Issues Arising from In Vitro Fertilization (1983), Report on Donor Gametes in IVF, Melbourne: Victorian Government Printing Office.
24. Committee to Consider the Social Ethical and Legal Issues Arising from In Vitro Fertilization (1984), Report on Disposition of Embryos Produced by IVF, Melbourne: Victorian Government Printing Office.
25. Commonwealth of Australia (2005), Senate Community Affairs Reference Committee - Inquiry Into Workplace Exposure to Toxic Dust: Terms of Reference, Canberra: Commonwealth Government.
26. Commonwealth of Australia (2006), The Senate: Community Affairs Reference Committee - Workplace Exposure to Toxic Dust, Canberra: Commonwealth Government.
27. Commonwealth Scientific and Industrial Research Organization (CSIRO) (1997), 'Media release - Australian scientists create a nanomachine', 97/109, Sydney: CSIRO.
28. CSIRO (1999), 'Media release - an ultrafine way to prevent skin cancer', 26 May, Sydney: CSIRO.
29. CSIRO (2003), 'Media release - Nanohouse brings nanotechnology home', accessed at www.csiro.au/files/mediaRelease/mr2003/Prnanohouse.htm, 19 November.
30. Davies, J. C. (2006), Managing the Effects of Nanotechnology, Washington, DC: Woodrow Wilson International Centre for Scholars.
31. Department of Health and Ageing (2005), Department of Health and Ageing 2004-05 Annual Report, Canberra: Department of Health and Ageing.
32. Department of Industry Science and Technology (1995), Annual Report 1994-1995, Canberra: Commonwealth of Australia.
33. Dunn, J. (2004), 'A mini revolution', Food Manufacture, 1 September, 49, accessed at www.foodmanufacture.co.uk/news/.
34. Environmental Law Institute (2005), Securing the Promise of Nanotechnology: Is US Environmental Law Up to the Job?, Washington, DC: Environmental Law Institute.
35. Ernst & Young (2002), Smaller, Cleaner, Cheaper, Faster, Smarter: Nanotechnology Applications and Opportunities in Australia, Canberra: Commonwealth Department of Industry, Tourism and Resources.
36. ETC Group (2004), Down on the Farm, Ottawa: ETC Group.
37. Food Standards Australia New Zealand (2005), FSANZ Annual Report 2004-2005, Canberra: FSANZ.
38. Food Standards Australia New Zealand (2006a), 'Food Standards Australia New Zealand - about us', accessed at www.foodstandards.gov.au/aboutus.
39. Food Standards Australia New Zealand (2006b), Australian New Zealand Food Standards Code, Canberra: FSANZ.
40. Friends of the Earth (2005), 'Submission from Friends of the Earth Australia - to the Senate Community Affairs Committee Inquiry into workplace exposure to toxic dust', Sydney: Friends of the Earth, accessed at www.aph.gov.au/senate/committee/clac_ctte/toxic_dust/submissions/sublist.html.
41. Friends of the Earth (2006a), An Analysis by Friends of the Earth of the National Nanotechnology Strategy Taskforce Report: 'Options for a National Nanotechnology Strategy', Melbourne: Friends of the Earth.
42. Friends of the Earth (2006b), Nanomaterials, Sunscreens and Cosmetics: Small Ingredients, Big Risks, Sydney: Friends of the Earth Australia and Friends of the Earth US.
43. Gardiner, D. (2003), 'Aussies bask in the summer sun, nanopowders protecting their skin', Small Times, 7 January.
44. Gardner, E. (2002), 'Brainy food: academia, industry sink their teeth into edible nano', Small Times, 21 June.
45. GeneEthics Network (2005), 'Submission to the Senate References Committee on exposure to toxic dust, including nanoparticles', Melbourne: GeneEthics Network, accessed at www.aph.gov.au/senate/committee/clac_ctte/toxic_dust/submissions/sublist.html.
46. Helmut Kaiser (2004), Study: Nanotechnology in Food and Food Processing Industry Wide 2003-2006-2010-2015, Tübingen: Helmut Kaiser Consultancy.
47. Hepburn, J. (2006), 'Size matters, public opinion doesn't', Canberra Times, 8 May.
48. Infertility Treatment Authority (ITA) (1999), Annual Report, Melbourne: ITA.
49. Invest Australia (2005), Australian Nanotechnology - Capability & Commercial Potential, Canberra: Australian Government.
50. Lademann, J., N. Otberg, H. Richter, H.-J.Weigmann, U. Lindemann, H. Schaefer and W. Sterry (2001), 'Investigation of follicular penetration of topically applied substances', Skin Pharmacology and Applied Skin Physiology, 14, 17-22.
51. Lofgren, H. and M. Benner (2003), 'Biotechnology and governance in Australia and Sweden: path dependency or institutional convergence?', Australian Journal of Political Science, 38 (1), 25-43.
52. Lux Research Inc (2006), The Nanotech Report, 4th edn, New York: Lux Research Inc.
53. Macfarlane, I. (2006a), A Big Strategy for Nanotech: The Industry of the Small, 5 April, Canberra: Department of Industry, Tourism and Resources.
54. Macfarlane, I. (2006b), 'Media release: report into the technology of the small - nanotech 06/362', 12 September, Canberra: Minister for Industry, Tourism and Resources.
55. Marchant, G. E. and D. J. Sylvester (2006), 'Transnational models for regulation of nanotechnology', The Journal of Law, Medicine & Ethics, 34 (4), 714-25.
56. Mazzola, L. (2003), 'Commercializing nanotechnology', Nature Biotechnology, 21 (10), 1137-43.
57. Mee, W., R. Lovel, F. Solomon, A. Kearns, F. Cameron and T. Turney (2004), Nanotechnology: The Bendigo Workshop, Melbourne: CSIRO Minerals.
58. Micronisers Pty Ltd (2005), 'Micronisers - about us . . .', Micronisers: Dandenong, accessed at www.micronisers.com/about.htm, 20 June 2006.
59. Minerals Council of Australia (2005), 'Senate Committee Affairs Reference Committee: inquiry into workplace exposure to toxic dust', Canberra: MCA, accessed at www.aph.gov.au/senate/committee/clac_ctte/toxic_dust/submissions/sublist.html.
60. Nanotechnology Victoria (Nano Vic) (2006a), 'NanoVic - background', accessed at www.nanovic.com.au/index.php?a=about_nanovic.about_us&p=11.
61. Nanotechnology Victoria (2006b), 'Nanotechnology Victoria: list of Australian nanotechnology companies', Industry Survey, August.
62. National Nanotechnology Strategy Taskforce (2006), Options for a National Nanotechnology Strategy - Report to Minister Industry, Tourism and Resources, Canberra: NNST.
63. National Industrial Chemicals Notification and Assessment Scheme (NICNAS) (2000), Annual Report 1999/2000, Canberra: NICNAS - Department of Health and Ageing.
64. NICNAS (2004), 'About NICNAS and chemical regulation in Australia', NICNAS - Department of Health and Ageing, accessed at www.nicnas.gov.au.
65. NICNAS (2005a), 'Chemicals schemes at a glance', NICNAS - Department of Health and Ageing, accessed at www.nicnas.gov.au, 12 April 2006.
66. NICNAS (2005b), A Compliance Guide for Introducers of Industrial Chemicals: A Checklist Approach, Canberra: NICNAS - Department of Health and Ageing.
67. NICNAS (2005c), 'Cosmetics - your online guide', NICNAS - Department of Health and Ageing, accessed at www.nicnas.gov.au/Cosmetics.asp.
68. NICNAS (2006), NICNAS Information Sheet - Nanomaterials, Canberra: NICNAS - Department of Health and Ageing.
69. Oberdörster, G., A. Maynard, K. Donaldson, V. Castronova, J. Fitzpatrick, K. Ausman, J. M. Carter, B. Karn, W. Kreyling, D. Lai, S. Olin, N. A. Monteiro-Riviere, D. Warheit and H. Yang (2005), 'Review: principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy', Particle and Fibre Toxicology, 2 (8), 1-35.
70. O'Neill, G. (2005), 'The next small thing', The Age, 12 September.
71. Prime Minister's Science Engineering and Innovation Council (1999), Nanotechnology - The Technology of the 21st Century: The Economic Impact of Emerging Nanometre Scale Technology, Canberra: PMSEIC.
72. Prime Minister's Science Engineering and Innovation Council (2005), Nanotechnology: Enabling Technologies for Australian Innovative Industries, Canberra: Commonwealth of Australia.
73. Roach Anleu, S. L. (2001), 'The Legal Regulation of Medical Science', Law & Policy, 23 (4), 417-40.
74. Roco, M. C. (2005), 'The emergence and policy implications of converging new technologies integrated from the nanoscale', Journal of Nanoparticle Research, 7, 129-43.
75. Rolland, A., N. Wagner, A. Chatelus, B. Shroot and H. Schaefer (1993), 'Sitespecific drug delivery to pilosebaceous structures using polymeric microspheres', Pharmaceutical Research, 10 (12), 1738-44.
76. Rowan, D. (2004), 'Are scientists putting you off your dinner?', The Guardian, 16 May.
77. Royal Society and Royal Academy of Engineering (2004), Nanoscience and Nanotechnologies: Opportunities and Uncertainties, London: RS-RAE.
78. Samsung Australia (2006), 'Silver Nano Health System - Silver Nano products', accessed at www.samsung.com.au/silvernano/, 8 May.
79. Seaton, A. and K. Donaldson (2005), 'Nanosciencce, nanotoxicology, and the need to think small', The Lancet, 365, 923-4.
80. Shefer, A. (2005), 'The application of nanotechnology in the food industry', The International Review of Food Science and Technology, 3.
81. Shelke, K. (2005), 'Hidden ingredients take cover in a capsule', Food Processing, accessed 29 September at www.foodprocessing.com/articles/2005/421.html.
82. Standards Australia and Standards New Zealand (1998), Australian/New Zealand Standard (AS/NZS) 2604:1998 Sunscreen Products - Evaluation and Classification, Sydney and Wellington: AS/NZS.
83. Swiss Re (2004), Nanotechnology: Small Matter, Many Unknowns, Geneva: Swiss Re.
84. Therapeutic Goods Administration (TGA) (2003), Australian Regulatory Guidelines for OTC Medicines, Canberra: TGA.
85. Therapeutic Goods Administration (TGA) (2006a), 'Safety of sunscreens containing nanoparticles of zinc oxide or titanium dioxide', accessed at www.tga.gov.au/npmeds/sunscreen-zotd.htm.
86. Therapeutic Goods Administration (TGA) (2006b), A Review of the Scientific Literature on the Safety of Nanoparticulate Titanium Dioxide and Zinc Oxide in Sunscreens, Canberra: TGA.
87. Toll, R., U. Jacobi, H. Richter, J. Lademann, H. Schaefer and U. Blume-Peytavi (2004), 'Penetration profile of microspheres in follicular targeting of terminal hair follicles', The Journal of Investigative Dermatology, 14, 17-22.
88. Turney, T. (2006), Personal communication with Graeme Hodge and Diana Bowman, Melbourne, 19 June.
89. Vogt, A., B. Combadiere, S. Hadam, K. M. Stieler, J. Lademann, H. Schaefer, B. Utran, W. Sterry and U. Blume-Peytavi (2006), '40 nm, but not 750 or 1500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin', Journal of Investigative Dermatology, 126, 1316-22.
90. Waller, L. (1992), 'Australia: the law and infertility - the Victorian experience', in S. McLean (ed.), Law Reform and Human Reproduction, Aldershot: Dartmouth.
91. Walters, L. (2004), 'Human embryonic stem cell research: an intercultural perspective', Kennedy Institute of Ethics Journal, 14 (1), 3-38.
92. Wang, J. and P. J. Dortmans (2004), A Review of Selected Nanotechnology Topics and Their Potential Military Applications, Canberra: Defence Science and Technology Organization and Department of Defence.
93. Warris, C. (2004), Nanotechnology Benchmarking Project, Canberra: Australian Academy of Science.
94. Wolfe, J. (2005), 'Safer and guilt-free nano foods', Forbes, July.
95. Woodrow Wilson International Center for Scholars (2006), 'Nano-product inventory - analysis of on-line inventory', accessed at www.nanotechprogect.org/index.php?id=44, 12 May.